Home
About
Overview
Sharing Data
ORCID
Help
History (1)
One-year safety and efficacy of tobramycin powder for inhalation in patients with cystic fibrosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
One-year safety and efficacy of tobramycin powder for inhalation in patients with cystic fibrosis.
One-year safety and efficacy of tobramycin powder for inhalation in patients with cystic fibrosis. Pediatr Pulmonol. 2016 Apr; 51(4):372-8.
View in:
PubMed
subject areas
Administration, Inhalation
Adolescent
Anti-Bacterial Agents
Child
Cystic Fibrosis
Double-Blind Method
Female
Humans
Male
Microbial Sensitivity Tests
Powders
Pseudomonas aeruginosa
Pseudomonas Infections
Sputum
Tobramycin
Treatment Outcome
Young Adult
authors with profiles
Patrick A. Flume